Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Gene therapies again generated buzz at the 2024 AAO meeting—as they have at recent meetings—but perhaps most exciting were reports of a treatment that could partially restore severe vision loss fro...
Carl Zeiss Meditec featured its Micor 700 at the 2024 meeting of the American Academy of Ophthalmology in Chicago, Illinois, with presentations that included booth talks by select US surgeons who h...
Ophthalmology remains an appealing investment, driven largely by procedural growth. While hundreds of companies are working toward technology enhancements and innovative therapies, ophthalmology pr...
The explosive growth of artificial intelligence has generated both fear and excitement among many in the ophthalmic industry. As technology progresses, so do the conversations at major meetings, wi...
Several sessions at the 2024 American Academy of Ophthalmology meeting highlighted the trend of office-based surgery (OBS) and the option of oral sedation among practitioners. The consensus among t...
William Boyd, MD, deputy director of ophthalmology at the US FDA’s Office of New Drugs, had a quick answer when asked to name the biggest unmet need in ophthalmology. “We need and want more therapi...
The celebrations and excitement that accompanied the launch in 2023 of the first two drugs approved in the US for the treatment geographic atrophy (GA) gave way to a hangover and regrets at the 202...
Recent studies indicate that up to 6 percent of the US population is currently taking a GLP-1 receptor agonist, a class of drugs prescribed to help manage blood glucose levels for diabetes and weig...
Bausch + Lomb’s enVista Envy and J&J Vision’s Odyssey are two new trifocal IOLs that were shown at the 2024 AAO meeting in Chicago. They are expected to help reverse the decline in trifocal IOL sal...
New glaucoma lasers and surgical devices were shown at various venues during the 2024 AAO meeting, including Glaucoma Subspecialty Day and the Eyecelerator meeting. There was also an important upda...
Alcon launched at the 2024 AAO meeting two new retinal surgical devices—Unifeye for air-gas exchange and Unipexy for retinopexy. Each is a one-person, hand-held, single-use gas delivery device. The...
Expanding the donor pool was once again top of mind at the 2024 Cornea and Eye Banking Forum, held Oct. 18 in conjunction with the AAO meeting in Chicago, Illinois. The forum, supported by the Eye ...
Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...
Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...
Market Scope will be exhibiting at the 2024 AAO meeting, set for Oct. 18-21 at McCormick Place in Chicago. We will be located at Booth 4903. Contact us to set up a time to discuss any custom resear...
US glaucoma specialists have over 20 surgical options to treat their patients, but even more devices are available or in the pipeline outside the US, and their developers could seek FDA approval. M...
The use of complement inhibitors to slow the progression of geographic atrophy (GA) is shaping up as the fulcrum for changing how ophthalmologists deliver and get compensated for retina care. Two c...
The advantages and disadvantages of immediate sequential bilateral cataract surgery (ISBCS) took center stage during a 2023 AAO Refractive Day session that tasked Rupert Menapace, MD (Austria), wit...
Surgeons attending the Refractive Subspecialty Day at the 2023 AAO meeting in San Francisco debated the ideal treatment options for patients with moderate to high myopia. Practices shared widely di...
The 2023 meeting of the American Academy of Ophthalmology drew 15,661 in-person attendees Nov. 3-6 to Moscone Center in San Francisco, according to preliminary numbers released by the AAO. Another ...
Dry Eye: New products kept generating buzz around dry eye. Bausch + Lomb leaned into the promotion of Miebo, the new, first-in-class drug therapy that directly targets tear evaporation. Diagnostic ...
Eyecelerator awarded a total of $45 thousand in prize money to winning pitch challengers at its fall meeting, after emerging companies got a chance to work with accomplished industry veterans to re...
RxSight—already the fastest growing IOL company in the US—is conducting a controlled launch of an additional version of the Light Adjustable Lens (LAL), referred to as the LAL+. Stephen Slade, MD, ...
Trifocal IOLs went head-to-head with extended depth of focus lenses during the 2023 AAO Refractive Day program as Damien Gatinel, MD, PhD (France), advocated for trifocal models and Douglas Koch, M...
The University of California, San Francisco (UCSF), held its Ophthalmology Showcase on Nov. 3 to highlight both the school’s history of ophthalmic innovation and its role in future advancements. Th...
Sustainability sessions at the 2023 AAO meeting echoed the sentiment of the ESCRS and other ophthalmic meetings throughout the year. US ophthalmologists discussed how practices can implement protoc...
Notable diagnostic innovations showcased at the 2023 meeting of the American Academy of Ophthalmology were Topcon’s Tempo perimeter and Heidelberg Engineering’s Anterion anterior OCT platform. Also...
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.